SCHEMBL17909263

SCHEMBL17909263

CCCCCCCCCCCCOCCOCCOCCCC(=O)O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.64
PPARG P37231 7/20 0.64
PPARD Q03181 7/20 0.64
PPARA Q07869 7/20 0.64
HDAC11 Q96DB2 5/20 0.64
TSHR P16473 4/20 0.64
PTPN1 P18031 3/20 0.64
KMT2A Q03164 3/20 0.64
ALDH1A1 P00352 2/20 0.64
TLR2 O60603 2/20 0.64
TDP1 Q9NUW8 2/20 0.64
FABP4 P15090 2/20 0.64
MEN1 O00255 2/20 0.64
SLC22A6 Q4U2R8 1/20 0.64
SLC22A8 Q8TCC7 1/20 0.64
ESR1 P03372 1/20 0.64
ALOX15 P16050 1/20 0.64
PDE4A P27815 1/20 0.64
PDE3A Q14432 1/20 0.64
HSD17B10 Q99714 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17908520 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL17908635 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL17908759 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL17908855 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL17909555 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL17908903 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL17908859 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL17909678 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL17909547 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL17908523 1.00 GPR84 (0.64) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3048093-B1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF MORESCO CORP (JP) 2019-02-20 EP disclosed
US-10077229-B2 Ether-containing monoester compound and use thereof MORESCO CORPORATION (JP) 2018-09-18 US disclosed
EP-3048093-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF Moresco Corporation (JP) 2016-07-27 EP disclosed
US-20160200998-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF MORESCO CORPORATION (JP) 2016-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10077229-B2 Ether-containing monoester compound and use thereof SFN, CCNE2, HSD3B2 GPR84 2486/4885PPARG 1846/4885PPARD 1558/4885
US-20160200998-A1 ETHER-CONTAINING MONOESTER COMPOUND AND USE THEREOF SFN, CCNE2, MSMO1 GPR84 2516/4885PPARG 2196/4885PPARD 2057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.